Due to the astonishing facts contained within this article, Dermatology Consultants, P.C. continues to recommend Neutrogena  Sunblock SPF 55 formulated with helioplex (broad spectrum uva-uvb) and we look forward to carrying Anthelios Sunblock with Mexoryl (broad spectrum uva-uvb).

• More than 1 million new cases of skin cancer will be diagnosed in the United States this year.¹
• Both basal cell carcinoma and squamous cell carcinoma have a better than 95 percent five-year cure rate if detected and treated early.²
• An estimated 10,710 people will die of skin cancer this year, 7,910 from melanoma and 2,800 from other skin cancers.³
• There will be about 111,900 new cases of melanoma in 2006^.4  At current rates, one in 32 Americans have a lifetime risk of developing melanoma and one in 60 Americans have a lifetime risk of developing invasive melanoma.
• One American dies of melanoma every 67 minutes.  In 2006, 7,910 deaths will be attributed to melanoma – 5,020 men and 2,890 women.⁵  Older Caucasian males have the highest mortality rates from melanoma.
• More than 73 percent of skin cancer deaths are from melanoma.⁶ 
• Invasive melanoma is the fifth most common cancer in men and the seventh most common cancer in women.⁷ ** 
• Melanoma is the second most common cancer in women aged 20-29⁸.
• 1 in 5 Americans will develop some form of skin cancer during their lifetime. 9
• Five or more sunburns double your risk of developing skin cancer.¹⁰

^{1, 3, 4, 6, 7, 9} Source:  American Cancer Society’s 2006 Facts & Figures
**Excluding basal cell carcinoma and squamous cell carcinoma,
which together are the most common cancers in both sexes.

² Wong CS, Strange RC, Lear, JT. Basal cell carcinoma. BMJ 2003; 327(7418): 794-8.

⁵ Source:  The Burden of Skin Diseases 2005, Copyright 2005,
the Society for Investigative Dermatology and
the American Academy of Dermatology Association.

⁸ Source: National Cancer Institute, SEER database, 1996-2000.

¹⁰ Pfahlberg A, Kolmel KF, Gefeller O. Adult vs childhood susceptibility to melanoma:
Is there a difference? Arch Dermatol, Sep 2002; 138: 1234 - 1235.